BIOPHYTIS ANNONCE LES PREMIERS RÉSULTATS DE L'ÉTUDE DE PHASE 2 SARA-INT AVEC SARCONEOS (BIO101) DANS LA SARCOPÉNIE
Subscribe

02 Aug 2021 08:00 CEST

Company Name

BIOPHYTIS

ISN

FR0012816825

Market

Euronext Growth

Symbol

ALBPS

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1000309_20210730__FR_SARA_final_.pdf

Source

BIOPHYTIS

Provider

Les Echos

Attachments

  • Original document
  • Permalink

Disclaimer

Biophytis SA published this content on 02 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 August 2021 07:11:03 UTC.